SYMBIQ DUAL CHANNEL
Report
- Report Number
- 2921482-2010-00022
- Event Type
- Injury
- Date Received
- January 14, 2010
- Date of Event
- December 16, 2009
- Report Date
- December 17, 2009
- Manufacturer
- HOSPIRA, INC.
- Product Code
- FRN
- PMA / PMN Number
- K041550
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- OTHER
Narratives
THE DEVICE WAS NOT ISOLATED OR IDENTIFIED BY SERIAL NUMBER; THEREFORE, IT WILL NOT BE RETURNED FOR INVESTIGATION. THE CUSTOMER CONTACT STATED THAT DURING A MEETING WITH THE NURSING STAFF AFTER THE REPORTED EVENT, THE IMPORTANCE OF CLAMPING THE TUBING PRIOR TO REMOVING THE TUBING SET FROM THE SYMBIC PUMP WAS EMPHASIZED. THIS REPORT REPRESENTS ALL THE INFORMATION KNOWN BY THE REPORTER UPON QUERY BY HOSPIRA PERSONNEL.
THE CUSTOMER CONTACT REPORTED UNRESTRICTED FLOW. ON AN UNSPECIFIED DATE AND TIME, THE DEVICE WAS PROGRAMMED TO DELIVER FENTANYL 2500 MCG/250ML AND THE DELIVERY WAS STARTED. NO SPECIFIC PROGRAMMING PARAMETERS WERE PROVIDED. THE INTUBATED PATIENT WAS ON VENTILATOR ASSIST SUPPORT; HOWEVER, THE PATIENT WAS ABLE TO TAKE SOME BREATHS ON HER OWN. IN 2009 AT APPROXIMATELY 2215, THE CUSTOMER CONTACT REPORTED THE FENTANYL THERAPY WAS ORDERED TO BE DISCONTINUED PRIOR TO REMOVING THE PATIENT FROM THE VENTILATOR. AT THIS TIME, THE NURSE REMOVED THE TUBING SET FROM THE DEVICE WITHOUT CLOSING THE CLAMP ON THE TUBING SET. IT WAS REPORTED AFTER THAT THE TUBING SET WAS REMOVED FROM THE DEVICE, PATIENT RECEIVED A BOLUS OF APPROXIMATELY 50-70ML BOLUS OF FENTANYL. AFTER AN UNSPECIFIED LENGTH OF TIME, THE NURSE NOTED THE PATIENT WAS APNEIC. THE CUSTOMER CONTACT REPORTED THE PATIENT WAS TREATED WITH ONE HOUR OF FULL VENTILATOR SUPPORT AND RETURNED TO THE STATUS PRIOR TO EVENT. NO FURTHER MEDICAL INTERVENTIONS WERE REQUIRED. THOUGH REQUESTED, NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SYMBIQ DUAL CHANNEL | 80FRN | FRN | HOSPIRA, INC. | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 30 YR | Life Threatening| R | FENTANYL, MANUFACTURER UNK |